Action Alert! Ask Your Representative to Cosponsor the Freedom of Choice Bill!

FDA currently allows the use, on a case-by-case basis, of an investigational drug outside of a clinical trial to treat a patient with a serious or immediately life-threatening disease or condition who has no comparable or satisfactory alternative treatment options. However, FDA often denies this access. A new bill, to be introduced shortly, would change FDA’s “compassionate use” rule so that individuals who have exhausted all conventional cancer treatments can have all of their treatment choices honored without need to obtain federal government approval—essentially removing FDA from the process.

A briefing and a screening of the documentary Cut Poison Burn will be held so that members of Congress and their staff can learn about the soon-to-be-introduced Freedom of Choice Bill. Under it, any patient diagnosed with a terminal illness, for whom a physician determines FDA approved drugs are likely not curative, may obtain access to any experimental drug upon execution of an informed consent without need for FDA approval.

Please ask your representative to attend the briefing and screening, and ask him or her to cosponsor the Freedom of Choice Bill when it is introduced.

Please personalize your message if you have the time!


  • Your Representative


*Required fields


Dear [Decision Maker],

[Your Name]
[Your Address]
[City, State ZIP]